← TransMedics Group, Inc. TMDX
Market Price
$88.72
Market Cap
$3.09B
P/E Ratio
N/A
Revenue (FY 2025)
↑0.2% YoY
$12.72M
3-Yr CAGR: -48.6%
Net Income
↑436.6% YoY
$190.29M
Net Margin: 1,495.9%
Free Cash Flow
↑308.8% YoY
$191.09M
FCF Yield: 6.18%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity
Efficiency
40.2%
ROA: 17.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TMDX)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2018 | $13.0M | — | $5.7M | $-23.8M | — | — | — | $-26.0M | $-26.4M | — |
| FY 2019 | $6.1M | -53.5% | $13.9M | $-33.5M | -41.2% | — | — | $-32.3M | $-32.5M | -22.9% |
| FY 2020 | $7.6M | +25.9% | $16.6M | $-28.7M | +14.3% | — | — | $-30.3M | $-30.7M | +5.3% |
| FY 2021 | $30.3M | +296.8% | $21.2M | $-44.2M | -53.8% | — | — | $-28.9M | $-30.1M | +2.1% |
| FY 2022 | $93.5M | +208.8% | $65.3M | $-36.2M | +18.1% | — | — | $-45.8M | $-45.9M | -52.6% |
| FY 2023 | $12.8M | -86.3% | $154.1M | $-25.0M | +30.9% | — | — | $-13.0M | $-15.5M | +66.3% |
| FY 2024 | $12.7M | -1.2% | $262.1M | $35.5M | +241.7% | — | — | $48.8M | $46.7M | +401.9% |
| FY 2025 | $12.7M | +0.2% | $362.8M | $190.3M | +436.6% | — | — | $192.8M | $191.1M | +308.8% |
Valuation
Market Price
$88.72
Market Cap
$3.09B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
6.48
FCF Yield
6.18%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
2,852.02%
Operating Margin
845.23%
Net Margin
1,495.88%
Return on Equity (ROE)
40.22%
Return on Assets (ROA)
17.81%
Asset Turnover
0.01x
Revenue 3-Yr CAGR
-48.56%
Financial Health & Liquidity
Current Ratio
0.26
Cash Ratio
N/A
Debt / Equity
1.083
Debt / Assets
0.480
Cash & Equivalents
N/A
Total Debt
$512.39M
Book Value / Share
$13.69
Cash Flow Efficiency
Operating Cash Flow
$192.84M
Capital Expenditures (CapEx)
$1.75M
Free Cash Flow
$191.09M
OCF / Revenue
1,515.92%
FCF / Revenue
1,502.14%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
N/A
EPS (Basic)
N/A
Dividends / Share
N/A
Book Value / Share
$13.69
EPS YoY Growth
N/A
Balance Sheet (FY 2025)
Total Assets
$1.07B
Total Liabilities
$1.07B
Stockholders' Equity
$473.10M
Current Assets
$16.25M
Current Liabilities
$62.74M